RNA Leaders Europe Congress

Event info


Oral presentation title: Unlocking the potential of Axiomer® platform to develop transformative RNA editing therapies

Presenter: Daniel A. de Boer, Founder and CEO, ProQR Therapeutics

Date: Thursday, March 16 – 14:35 CET

Abstract: The presentation will describe: Axiomer, the next-generation RNA technology using the cell’s own editing machinery; explore therapeutic opportunities of Axiomer, beyond disease-causing mutations; and the advancement of Axiomer through in-house pipeline programs and partnering strategy.

You might like this